A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo.

e19533 Background: Despite the introduction of stem cell transplantation and novel agents (proteasome inhibitors, immunomodulatory drugs) for treatment of multiple myeloma (MM), a substantial numbe...